Laura Hermans SPRL

Laura Hermans reported total assets of 975,004 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Sep 2026).

Company number (CBE) 0849.853.622 · VAT BE0849853622
3001 Leuven
active in Research and experimental development on biotechnology (NACE 72101)
operating since 19 Oct 2012 (≈ 14 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Laura Hermans shows with a free account.

See the score
Profile
SPRL since 2012
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result9,600 €
Equity203,862 €
Cash5,077 €
EBITDA75,554 €
Total assets975,004 €
The line marks its sector median: 60.4% (425 companies).

Change 2022 → 2025: Equity +26 % Total assets +82 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Laura Hermans's annual accounts

20252024202320222021
Net result9,600 €
Equity203,862 €
Cash5,077 €
EBITDA75,554 €
Total assets975,004 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 28 Sep 2026
  • Year ended 31 Dec 2024filed on 29 Aug 2025
  • Year ended 31 Dec 2023filed on 28 Sep 2024
  • Year ended 31 Dec 2022filed on 31 Aug 2023
  • Year ended 31 Dec 2021filed on 31 Oct 2022

Laura Hermans's financial analysis

Management and control of Laura Hermans

1 active director(s) in the register.

Laura Hermans's shareholders and holdings →

Laura Hermans's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0849.853.622
VAT number
BE0849853622
Peppol
Registered · 0208:0849853622 · as of 10 Nov 2026
Legal form
SPRL
Incorporated
19 Oct 2012
Registered office
3001 Leuven
Latest accounts
2025 · filed on 28 Sep 2026
Activity
Research and experimental development on biotechnology (NACE 72101)

Laura Hermans (SPRL) has been based in Leuven since 2012, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 9,600 € and equity of 203,862 €; its revenue is not published. Its solvency stands at 20.9%, below the median of its sector (60.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Laura Hermans

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Laura Hermans

What is the revenue of Laura Hermans?

Laura Hermans files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Laura Hermans?

In Belgium, the VAT number is the company number prefixed with BE: BE0849853622 for Laura Hermans, if the company is VAT-registered. Its company number (CBE) is 0849.853.622.

Where is the registered office of Laura Hermans?

According to the CBE register, the registered office of Laura Hermans is in 3001 Leuven.

What is the equity of Laura Hermans?

At the close of the 2025 financial year, the equity of Laura Hermans amounts to 203,862 €, a solvency of 20.9% of total assets.

Who manages Laura Hermans?

The register lists 1 active mandates at Laura Hermans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Laura Hermans

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 29 Sep 2026

No credit card, no commitment.

What each plan unlocks →